Jhon Rojas

2.5k total citations
19 papers, 355 citations indexed

About

Jhon Rojas is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Jhon Rojas has authored 19 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 8 papers in Virology and 6 papers in Emergency Medicine. Recurrent topics in Jhon Rojas's work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (9 papers) and HIV Research and Treatment (8 papers). Jhon Rojas is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (9 papers) and HIV Research and Treatment (8 papers). Jhon Rojas collaborates with scholars based in Spain, United Kingdom and Australia. Jhon Rojas's co-authors include Estebán Martínez, Josep Mallolas, Ana González-Cordón, José Luís Blanco, María Ángeles Marcos, Maria Martínez‐Rebollar, Montserrat Laguno, Elisa de Lazzari, Montserrat Loncà and José M. Gatell and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Bone and Mineral Research.

In The Last Decade

Jhon Rojas

18 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jhon Rojas Spain	11	296	141	86	77	39	19	355
Pilar Vizcarra Spain	12	281 0.9×	49 0.3×	57 0.7×	67 0.9×	7 0.2×	49	388
Arturo Ciccullo Italy	13	430 1.5×	307 2.2×	148 1.7×	126 1.6×	3 0.1×	70	510
Ashwaq Hermes United States	7	277 0.9×	174 1.2×	80 0.9×	58 0.8×	6 0.2×	8	359
Luigi Pusterla Italy	7	245 0.8×	138 1.0×	144 1.7×	92 1.2×	29 0.7×	8	366
Carlos Seas Peru	8	157 0.5×	36 0.3×	142 1.7×	75 1.0×	20 0.5×	20	293
Vincenzo Scaglione Italy	11	111 0.4×	27 0.2×	21 0.2×	97 1.3×	29 0.7×	40	353
Nomathemba Chandiwana South Africa	9	474 1.6×	248 1.8×	372 4.3×	105 1.4×	9 0.2×	26	628
Masebole Masenya South Africa	4	366 1.2×	195 1.4×	303 3.5×	78 1.0×	13 0.3×	4	481
Nicole Engen United States	9	175 0.6×	55 0.4×	81 0.9×	105 1.4×		18	275
Davide Minisci Italy	9	257 0.9×	39 0.3×	54 0.6×	71 0.9×	3 0.1×	18	326

Countries citing papers authored by Jhon Rojas

Since Specialization

Citations

This map shows the geographic impact of Jhon Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jhon Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jhon Rojas more than expected).

Fields of papers citing papers by Jhon Rojas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jhon Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jhon Rojas. The network helps show where Jhon Rojas may publish in the future.

Co-authorship network of co-authors of Jhon Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Jhon Rojas. A scholar is included among the top collaborators of Jhon Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jhon Rojas. Jhon Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Blanco, José Luís, Jhon Rojas, Elisa de Lazzari, et al.. (2022). Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study. Journal of Antimicrobial Chemotherapy. 77(7). 1974–1979.

Rojas, Jhon, Elisa de Lazzari, Eugènia Negredo, et al.. (2021). Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. The Lancet HIV. 8(8). e463–e473. 13 indexed citations

Laguno, Montserrat, Ainoa Ugarte, Maria Martínez‐Rebollar, et al.. (2021). Experiencia de un programa de profilaxis preexposición en una unidad de virus de la inmunodeficiencia humana hospitalaria. Descripción del perfil basal del usuario e identificación de oportunidades de mejora. Enfermedades Infecciosas y Microbiología Clínica. 41(1). 24–28. 2 indexed citations

Tiraboschi, Juan, Jhon Rojas, Henrik Zetterberg, et al.. (2020). No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62). The Journal of Infectious Diseases. 223(11). 1928–1933. 7 indexed citations

Bañó, M. Carmen, Constanza Morén, Mariona Guitart‐Mampel, et al.. (2020). Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients. Frontiers in Genetics. 11. 497–497. 13 indexed citations

Inciarte, Alexy, Ana González-Cordón, Jhon Rojas, et al.. (2020). Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS. 34(12). 1775–1780. 73 indexed citations

Lazzari, Elisa de, Montserrat Loncà, Jhon Rojas, et al.. (2019). A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine. AIDS. 33(12). 1891–1896. 8 indexed citations

Carr, Andrew, Stephen J. Kerr, Peter R. Ebeling, et al.. (2019). Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study. Journal of Bone and Mineral Research. 34(12). 2192–2197. 14 indexed citations

Hoy, Jennifer, Peter R. Ebeling, Jhon Rojas, et al.. (2018). Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV. AIDS. 32(14). 1967–1975. 18 indexed citations

10.

Rojas, Jhon, José Luís Blanco, Sonsoles Sánchez‐Palomino, et al.. (2018). A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity. AIDS. 32(12). 1633–1641. 10 indexed citations

11.

Lazzari, Elisa de, Jhon Rojas, Ana González-Cordón, et al.. (2017). Tolerability of integrase inhibitors in a real-life setting. Journal of Antimicrobial Chemotherapy. 72(6). 1752–1759. 76 indexed citations

12.

Rojas, Jhon, et al.. (2016). A NEW ENHANCED SORBITOL: CALCIUM DIPHOSPHATE COMPOSITE AS A DIRECT COMPRESSION EXCIPIENT: A COMPARATIVE STUDY. International Journal of Pharmacy and Pharmaceutical Sciences. 8(4). 43–49. 1 indexed citations

13.

Rojas, Jhon, José Luís Blanco, María Ángeles Marcos, et al.. (2016). Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression. Journal of Antimicrobial Chemotherapy. 71(7). 1975–1981. 32 indexed citations

14.

Leal, Lorna, Agathe León, Berta Torres, et al.. (2016). A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection. Journal of Antimicrobial Chemotherapy. 71(7). 1982–1986. 11 indexed citations

15.

Curran, Adrián, Jhon Rojas, Alfonso Cabello, et al.. (2016). Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients. Journal of Antimicrobial Chemotherapy. 71(12). 3510–3514. 4 indexed citations

16.

Leal, Lorna, Agathe León, Berta Torres, et al.. (2016). A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection. Journal of Antimicrobial Chemotherapy. 71(7). 1987–1993. 17 indexed citations

17.

Llibre, Josep M., Antonio Rivero, Jhon Rojas, et al.. (2015). Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes. Antiviral Research. 120. 79–84. 13 indexed citations

18.

Podzamczer, Daniel, Jhon Rojas, Elena Ferrer, et al.. (2014). Effectiveness and tolerability of abacavir‐lamivudine‐nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV‐infected, ARV‐naïve patients. Journal of the International AIDS Society. 17(4S3). 19773–19773. 1 indexed citations

19.

Morata, Laura, Jhon Rojas, Merçè Brunet, et al.. (2013). Risk Factors for a Low Linezolid Trough Plasma Concentration in Acute Infections. Antimicrobial Agents and Chemotherapy. 57(4). 1913–1917. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact